Synapse - Gynecology Disease Management Team

Results (5144)

Rejuvenating dysfunctional T cells in ovarian cancer: CD28 is the license to kill

Editorial

Uhlitz, F.; Zamarin, D.
Cancer Cell (2021)

Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement

Guidelines

King, M. T.; Keyes, M.; Frank, S. J.; Crook, J. M.; Butler, W. M.; Rossi, P. J.; Cox, B. W.; Showalter, T. N.; Mourtada, F.; Potters, L.; more...
Brachytherapy (2021)

Fulltext@MSK | Save

Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer

Journal Article

Gorovets, D.; Hopkins, M.; Kollmeier, M.; Moore, A.; Goel, A.; Shasha, D.; Brennan, V.; McBride, S.; Cohen, G.; Damato, A. L.; more...
Brachytherapy (2021)

Fulltext@MSK | Save

Insufficient evidence of endocervical origin in germline BRCA1 and MSH2-associated tumors

Correspondence

Kertowidjojo, E.; Park, K. J.; Hodgson, A.
Tumori (2021)

Fulltext@MSK | Save

Diverse alterations associated with resistance to KRAS(G12C) inhibition

Journal Article

Zhao, Y.; Murciano-Goroff, Y. R.; Xue, J. Y.; Ang, A.; Lucas, J.; Mai, T. T.; Da Cruz Paula, A. F.; Saiki, A. Y.; Mohn, D.; Achanta, P.; more...
Nature (2021)

Fulltext@MSK | Save

A perception-based nanosensor platform to detect cancer biomarkers

Journal Article

Yaari, Z.; Yang, Y.; Apfelbaum, E.; Cupo, C.; Settle, A. H.; Cullen, Q.; Cai, W.; Long Roche, K.; Levine, D. A.; Fleisher, M.; more...
Science Advances (2021)

Fulltext@MSK | Save

Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors

Journal Article

Elkin, R.; Oh, J. H.; Liu, Y. L.; Selenica, P.; Weigelt, B.; Reis-Filho, J. S.; Zamarin, D.; Deasy, J. O.; Norton, L.; Levine, A. J.; more...
npj Genomic Medicine (2021)

Fulltext@MSK | Save

Recurrent ovarian cancer - Sculpting a promising future with surgery

Editorial

Gardner, G. J.; Chi, D. S.
New England Journal of Medicine (2021)

Fulltext@MSK | Save

Endometrial cancer

Review

Makker, V.; MacKay, H.; Ray-Coquard, I.; Levine, D. A.; Westin, S. N.; Aoki, D.; Oaknin, A.
Nature Reviews Disease Primers (2021)

Fulltext@MSK | Save

Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial

Journal Article

Banerjee, S.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; more...
Lancet Oncology (2021)

Fulltext@MSK | Save